BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
25 results:

  • 1. Inhaled anesthesia associated with reduced mortality in patients with stage III breast cancer: A population-based study.
    Kuo ET; Kuo C; Lin CL
    PLoS One; 2024; 19(3):e0289519. PubMed ID: 38427628
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Associations between marital quality and the prognosis of breast cancer in young Chinese women: 10.3-year median follow-up.
    Yuan L; Cai H; An W; Yuan W; Toloza EM; Song Y; An J
    Chin Clin Oncol; 2023 Oct; 12(5):51. PubMed ID: 37872116
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-Term Risk of Being Bedridden in Elderly Patients Who Underwent Oncologic Surgery: A Retrospective Study Using a Japanese Claims Database.
    Konishi T; Sasabuchi Y; Matsui H; Tanabe M; Seto Y; Yasunaga H
    Ann Surg Oncol; 2023 Aug; 30(8):4604-4612. PubMed ID: 37149549
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy.
    Ma Y; Lv M; Yuan P; Chen X; Liu Z
    BMC Cancer; 2023 Mar; 23(1):208. PubMed ID: 36870942
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
    Tolaney SM; Tarantino P; Graham N; Tayob N; Parè L; Villacampa G; Dang CT; Yardley DA; Moy B; Marcom PK; Albain KS; Rugo HS; Ellis MJ; Shapira I; Wolff AC; Carey LA; Barroso-Sousa R; Villagrasa P; DeMeo M; DiLullo M; Zanudo JGT; Weiss J; Wagle N; Partridge AH; Waks AG; Hudis CA; Krop IE; Burstein HJ; Prat A; Winer EP
    Lancet Oncol; 2023 Mar; 24(3):273-285. PubMed ID: 36858723
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
    Guo B; Wang Y; Liu W; Zhang S
    Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.
    Xi G; Qiu L; Xu S; Guo W; Fu F; Kang D; Zheng L; He J; Zhang Q; Li L; Wang C; Chen J
    BMC Med; 2021 Nov; 19(1):273. PubMed ID: 34789257
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis.
    Wang G; Zhang S; Wang M; Liu L; Liu Y; Tang L; Bai H; Zhao H
    BMC Cancer; 2021 Jul; 21(1):875. PubMed ID: 34330233
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Large-scale tumor-associated collagen signatures identify high-risk breast cancer patients.
    Xi G; Guo W; Kang D; Ma J; Fu F; Qiu L; Zheng L; He J; Fang N; Chen J; Li J; Zhuo S; Liao X; Tu H; Li L; Zhang Q; Wang C; Boppart SA; Chen J
    Theranostics; 2021; 11(7):3229-3243. PubMed ID: 33537084
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Retrospective assessment of cyclin-dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer.
    Saidy B; Rakha EA; Green AR; Ellis IO; Martin SG; Storr SJ
    J Cell Mol Med; 2020 Jun; 24(11):6263-6271. PubMed ID: 32352232
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.
    D'Angelo A; Sobhani N; Roviello G; Bagby S; Bonazza D; Bottin C; Giudici F; Zanconati F; De Manzini N; Guglielmi A; Generali D
    PLoS One; 2019; 14(8):e0219566. PubMed ID: 31381571
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer.
    Jääskeläinen A; Jukkola A; Risteli J; Haapasaari KM; Karihtala P
    Tumour Biol; 2019 May; 41(5):1010428319847081. PubMed ID: 31122159
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic role of cyclin D2/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis.
    Ding ZY; Li R; Zhang QJ; Wang Y; Jiang Y; Meng QY; Xi QL; Wu GH
    Cancer Med; 2019 Jun; 8(6):2717-2729. PubMed ID: 30950241
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
    Wen HY; Krystel-Whittemore M; Patil S; Pareja F; Bowser ZL; Dickler MN; Norton L; Morrow M; Hudis CA; Brogi E
    Cancer; 2017 Jan; 123(1):131-137. PubMed ID: 27526056
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis.
    Jiang D; Gao Z; Cai Z; Wang M; He J
    BMC Cancer; 2015 Oct; 15():727. PubMed ID: 26475790
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
    Sebestyén E; Zawisza M; Eyras E
    Nucleic Acids Res; 2015 Feb; 43(3):1345-56. PubMed ID: 25578962
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature.
    Wang J; Guo Y; Wang B; Bi J; Li K; Liang X; Chu H; Jiang H
    Mol Biol Rep; 2012 Dec; 39(12):11153-65. PubMed ID: 23054001
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response.
    Godoy P; Cadenas C; Hellwig B; Marchan R; Stewart J; Reif R; Lohr M; Gehrmann M; Rahnenführer J; Schmidt M; Hengstler JG
    Breast Cancer; 2014 Jul; 21(4):491-9. PubMed ID: 23001506
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.
    Naidu R; Har YC; Taib NA
    Oncol Res; 2009; 18(2-3):65-71. PubMed ID: 20066896
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.